We therefore selected genes that were well-established as deregulated in these tumors to verify our results and then focused on deregulated genes in other tumors, as well as in our series, that had been insufficiently studied or not studied at all in schwannomas, such as MET, AR or CAV1. This evidence concerns the gene AR and schwannoma.